top_image

Research Activities

    The Department of Neuropsychopharmacology carries out research into problems concerning the various psychiatric disorders in the rapidly aging society of Japan. Especially, depression, anxiety disorders, schizophrenia and suicide are focused in the department. Our mission is to advance the understanding of the pathophysiology of these psychiatric disorders. This department also endeavors to develop evidence-based diagnosis, clinical guidelines, and therapeutic medical/social interventions.

Suicide prevention in patients with psychiatric disorders

[The HOPE program standards (in English)]
We publish The HOPE program standards in English, which guide the HOPE program start-up, practical implementation, and program monitoring by clearly defining the minimum requirements. Successful HOPE model implementation and demonstrated improvements in patient outcomes are best accomplished by close adherence to the HOPE program standards.


[The HOPE guidebook (in Japanese)]
The HOPE guidebook by the Japanese Association for Suicide Prevention (in Japanese) has published for dissemination and implementation of the assertive case management to prevent repeat suicide attempts among patients admitted to emergency departments for suicidal behavior.

Topics

2019-1001NEW.GIF - 8,963BYTES
Ms. Mami Terao from Senshu University has just joined to our research group.
2019-0401
Ms. Yuko Nakatake from Tokyo University of Science has just joined to our research group.
2018-1001
Dr. Momoko Kobayashi has just joined to our research group as a research fellow.
2018-0717
A position for a Post-Doc fellow is now closed. For inquiry, please contact us by an e-mail to [dhp06@ncnp.go.jp].
2018-0401
Dr. Hideki Miwa has just joined to our research group as a section chief (Section of Molecular Pharmacology).
2018-0401
Dr. Hiroki Furuie has just joined to our research group (Section of Drug Development).

last update 2020.2.28